⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 15, 2024Experimental GerontologyOpen Access

Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment

Lu Zhao Qi Qiu Shaowei Zhang Feng Yan Xia Li

View Full Paper

Ask AI

Bookmark

Share

Abstract

Glial fibrillary acidic protein (GFAP) and neurofilament light (NfL) are putative non-amyloid biomarkers indicative of ongoing inflammatory and neurodegenerative disease processes. Hence, this study aimed to demonstrate the relationship between plasma biomarkers (GFAP and NfL) and

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhao et al. (2024) studied this question.

synapsesocial.com/papers/68e5c0f4b6db643587558f1c https://doi.org/10.1016/j.exger.2024.112535

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline2024 · 59 citations
2Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression2024 · 18 citations
3Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression2024 · 2 citations
4Plasma P‐tau217, GFAP, and NfL as biomarkers for Alzheimer's disease: role in disease stratification, pathological progression, and cognitive decline2025 · 24 citations
5Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia2024 · 37 citations

More related papers

Association Between Plasma GFAP and Medial Temporal Atrophy and Cognition in Amyloid-Negative Cerebrovascular Disease2026
Longitudinal Associations Between Plasma GFAP, Cognition, Amyloid Burden, and Neurodegeneration in Preclinical Alzheimer’s Disease (P10-13.010)2026
Exploring the links between amyloid, astrocytic activation, and tau biomarkers in a memory clinic cohort across the Alzheimer’s disease continuum2026

More from Experimental Gerontology

The cardiometabolic ageing–cardiovascular disease axis: A 32-year European studyThu,
Associations of NHHR change patterns and cumulative NHHR with incident cardiovascular disease among individuals with CKM stages 0-3Tue,